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Sheep liver cytosolic aldehyde dehydrogenase: the structure
reveals the basis for the retinal specificity of class 1 aldehyde
dehydrogenases 
Stanley A Moore1, Heather M Baker1†, Treena J Blythe1, Kathryn E Kitson2,
Trevor M Kitson3 and Edward N Baker1†*
Background: Enzymes of the aldehyde dehydrogenase family are required for
the clearance of potentially toxic aldehydes, and are essential for the production
of key metabolic regulators. The cytosolic, or class 1, aldehyde dehydrogenase
(ALDH1) of higher vertebrates has an enhanced specificity for all-trans retinal,
oxidising it to the powerful differentiation factor all-trans retinoic acid. Thus,
ALDH1 is very likely to have a key role in vertebrate development.
Results: The three-dimensional structure of sheep ALDH1 has been
determined by X-ray crystallography to 2.35 Å resolution. The overall tertiary
and quaternary structures are very similar to those of bovine mitochondrial
ALDH (ALDH2), but there are important differences in the entrance tunnel for
the substrate. In the ALDH1 structure, the sidechain of the general base
Glu268 is disordered and the NAD+ cofactor binds in two distinct modes.
Conclusions: The submicromolar Km of ALDH1 for all-trans retinal, and its
600-fold enhanced affinity for retinal compared to acetaldehyde, are explained
by the size and shape of the substrate entrance tunnel in ALDH1. All-trans
retinal fits into the active-site pocket of ALDH1, but not into the pocket of
ALDH2. Two helices and one surface loop that line the tunnel are likely to have
a key role in defining substrate specificity in the wider ALDH family. The relative
sizes of the tunnels also suggest why the bulky alcohol aversive drug disulfiram
reacts more rapidly with ALDH1 than ALDH2. The disorder of Glu268 and the
observation that NAD+ binds in two distinct modes indicate that flexibility is a
key facet of the enzyme reaction mechanism.
Introduction
The retinoic acid signalling pathway in vertebrates utilises
the RXR/RAR family of ligand-dependent transcription
factors that bind 9-cis (RXR,RAR) or all-trans (RAR) retinoic
acid via a ligand-binding domain, and direct the transcrip-
tion of target genes via a DNA-binding domain [1,2].
Retinoic acid is derived from vitamin A (retinol) and its
pleiotropic effects include spinal chord and retina develop-
ment during embryogenesis, neuronal cell differentiation
and maintenance of epithelial cell type in adult tissues [3].
Although the retinoic acid signalling pathway is reasonably
well understood, it is less clear how spatiotemporal gradi-
ents of retinoic acid are maintained during developmental
processes, and which are the major enzymes responsible
for retinoic acid synthesis in various tissues [4].
The cloning and characterisation of several aldehyde dehy-
drogenases (ALDHs) showing a high specificity for retin-
aldehyde has recently been reported. Each of these
enzymes has been shown to belong to the broad family of
cytosolic or class 1 ALDH (ALDH1) enzymes [4,5]. Studies
on mouse embryos show that retinaldehyde-specific ALDH
activity co-localises with high concentrations of retinoic acid
in the developing spinal chord [6], and retinaldehyde dehy-
drogenase is a positional marker in the mouse embryonic
retina [7]. Retinal-specific ALDHs can be divided into
three groups on the basis of their amino acid sequence
and pI values [5]. The archetypal class 1 ALDH is found
predominantly in the liver of higher vertebrates including
horse, beef, sheep and man, and has a pI of 5.2. Two
retinal-specific variants of ALDH1 (RalDH-1 and -2) have
been characterised in the mouse and rat, but not in other
mammals. One of these, RalDH-1, is about 90% identical
to the other class 1 enzymes, has a pI of ~8.3 [7–10], and
effectively converts both 9-cis and all-trans retinal to the
corresponding retinoic acid [11,12]. The other enzyme,
RalDH-2, is only about 70% identical to the classical
ALDH1 enzymes, has a pI of 5.1, and is specific for oxidis-
ing retinaldehyde [13,14].
ALDHs are found in most mammalian tissues. In humans
alone, eight distinct ALDH alleles have been characterised
[15]. The liver has high ALDH activity, and in this tissue
there are two principal isozymes, ALDH1 and ALDH2.
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ALDH1 is cytosolic and ALDH2 is produced with a leader
peptide sequence and targeted to the mitochondrial matrix.
Human ALDH1 has been shown to have a submicromolar
Km for both all-trans retinal [16,17] and 9-cis retinal [5].
Kinetic studies of sheep ALDH1 indicate that it has a high
specific activity for both all-trans and 9-cis retinal, with a Km
value of 0.14 µM for both substrates [5]. Acetaldehyde is a
much poorer substrate for human ALDH1, with a Km of
180 µM [18]. In contrast, kinetic data suggest that acetalde-
hyde is the preferred substrate of human ALDH2, having a
Km value of 0.2 µM [18]. The presence of an alcohol-sensi-
tivity phenotype mapping to the human ALDH2 locus
[19–22] strongly indicates that the major biological function
of ALDH2 is to metabolise ethanol-derived acetaldehyde.
Human ALDH2 also has essentially no activity for all-trans
retinaldehyde [16], underscoring the complementary sub-
strate specificity of these two enzymes.
Both ALDH1 and ALDH2 are homotetramers comprising
subunits of 500 or 501 amino acids, and they require nicoti-
namide adenine dinucleotide (NAD+) as a cofactor [15].
The aligned ALDH1 and ALDH2 amino acid sequences
are approximately 69% identical, suggesting a high similar-
ity of their three-dimensional structures. The inducible
ALDH3 family of enzymes is much more distantly related
to ALDH1 and ALDH2, being only 30% identical at the
amino acid level, and lack an N-terminal segment present
in ALDH1 and ALDH2. In addition, whereas ALDH1 and
ALDH2 are homotetramers, ALDH3 is dimeric [23].
The enzymology and kinetics of sheep liver ALDH1 have
been investigated in detail [5,24–27]. For both ALDH1
and ALDH2, the dehydrogenase reaction follows an ordered
sequential pathway [24]. NAD+ binds first, followed by
binding of the aldehyde and formation of a thiohemiacetal
intermediate with the active-site nucleophile, which has
been identified as Cys302 [28–31]. The thiohemiacetal
then collapses to the thioester, giving up a hydride ion to
C4 of the nicotinamide ring of NAD+ in the process.
Hydride transfer has been shown to be stereospecific for
the class 3 enzymes, adding only to the Pro-R or A-side
of the nicotinamide ring [32]. The thioester is presum-
ably hydrolysed by a water molecule, which becomes
activated by the general base Glu268 [28,33,34]. Release
of the carboxylic acid, followed by NADH release, com-
pletes the reaction.
We have undertaken structural studies of sheep liver
ALDH1 in order to better understand the differences in
substrate specificity between ALDH1 and ALDH2, and
to obtain a clearer overall view of the mechanism and
function of this important family of enzymes. In particular,
we hoped to learn more about the role of ALDH1 in
retinoic acid synthesis. Our results will complement struc-
tural studies on other proteins involved in retinoid meta-
bolism, including those on the ligand-binding domain of
the retinoic acid receptor [35,36], and cellular proteins that
bind retinol [37,38] and retinoic acid [39,40].
Results
Structure solution and refinement
The three-dimensional structure of sheep liver ALDH1
was first solved by molecular replacement using the bovine
ALDH2 atomic coordinates as a search model. After
refinement against diffraction data in a triclinic unit cell
(Table 1), the completed sheep ALDH1 model includes
four polypeptides comprising an intact tetramer (each
polypeptide contains 494 amino acids; the first seven amino
acids are not included in our model due to apparent dis-
order), four NAD+ cofactors and a total of 140 water mol-
ecules (see Table 2). The R factor is 23.6% for all data to
2.35 Å resolution; the R free is 25.8%. The overall stereo-
chemistry for the ALDH1 atomic model is excellent with
root mean square deviations (rmsds) from standard geome-
try being 0.009 Å (for bonds) and 1.61° (for angles) with no
Ramachandran outliers. There are some local noncrystallo-
graphic symmetry (NCS) deviations, mostly due to small
rigid-body movements of mainchain atoms or alternate
sidechain conformers in the monomers. In this paper we
use the consensus amino acid sequence numbering for
ALDH1 and ALDH2 (e.g. Cys302, Glu268, etc.); this
results in the amino acid sequence starting at –1 for sheep
ALDH1. In addition, we make use of the secondary struc-
ture assignments for bovine ALDH2 [34], for consistency
and ease of comparison of the two structures.
Overall structure of sheep ALDH1 
A superposition of the refined sheep ALDH1 model on
the bovine ALDH2 atomic coordinates yields an rmsd in
mainchain atoms (N, Cα, C, O) of 0.74 Å for the entire
polypeptide chain (Figure 1a). This result is not surpris-
ing, given that the sheep ALDH1 amino acid sequence
[41] is about 69% identical to the bovine ALDH2
sequence. Omitting 16 outlying residues from the super-
position increases the structural agreement markedly, the
rms pairwise difference drops to 0.58 Å.
ALDH1 is made up of three domains: an N-terminal
NAD+-binding domain (residues 8–135 and 159–270) that is
novel to the ALDH family and contains a five-stranded par-
allel β sheet [23,34]; a catalytic domain (residues 271–470)
that contains a six-stranded parallel β sheet; and an oligo-
merisation domain made up of a three-stranded antiparallel
β sheet (residues 140–158 and 486–495). Both the NAD+-
binding and catalytic domains are based on topologically
related βαβ type polypeptide folds (Figure 1b).
The N-terminal NAD+-binding domains of ALDH enzymes
exhibit a unique mode of cofactor binding that appears to
be distantly related to the canonical NAD-binding domain
found in most NAD(P) utilising dehydrogenases, and has
been discussed in detail [23,34]. The sheep ALDH1
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structure expands the generality of the unique ALDH
NAD+-binding motif, as the general mode of NAD+ binding
observed first in ALDH3 [23] and then ALDH2 [34] is con-
served for the cofactor in our structure (Figure 1b).
The main differences in the ALDH1 and ALDH2 poly-
peptide conformations are localised to a particular region
of the structure that is in the vicinity of the substrate
entrance tunnel (Figures 1a and 2). In particular, residues
13–18 (rmsd 2.68 Å), residues 329–341 (rmsd 2.20 Å) and
residues 371–382 (rmsd 1.18 Å) in sheep ALDH1 are dis-
placed relative to the bovine ALDH2 structure. These
regions do not themselves have secondary structure, but
they do exert rigid-body displacements on α helices and β
sheets that are adjacent in the primary sequence. Helix
αJ (residues 347–364) is noteworthy because it makes up
one side of the NAD+-binding pocket, and is slightly dis-
placed relative to bovine ALDH2 (rmsd 0.84 Å). The
bottom of the substrate entrance tunnel makes up part of
the tetramer interface (see Figure 2) and includes helix
αM (residues 435–446, rmsd 0.91 Å) and the 468–469
peptide, both of which show displacements relative to
ALDH2. Other structural perturbations are observed at
the oligomerisation interface, including residues 139–140
and helix αN (residues 479–484, rmsd 1.14 Å).
The entrance tunnel for the retinal substrate
Certainly the most striking feature of the sheep ALDH1
three-dimensional structure is the large-scale change in
the entrance tunnel for the substrate relative to ALDH2.
The entrance to this tunnel is made up of two α helices
and a surface loop (Figure 2). Helix αC (residues 114–135)
makes up the left-hand side of the opening and forms part
of a three-helix bundle near the beginning of the N-termi-
nal domain. The back of the tunnel is made up by helix αD
(residues 170–185), which incidentally packs against helix
αC. Helix αD is also the first α helix of the canonical
Rossmann fold of the N-terminal domain. Helix αH
(residues 282–296) makes up the bottom of the substrate
entrance tunnel, as viewed in Figure 2, and originates
from the catalytic domain, immediately preceding the
active-site nucleophile (Cys302). The right-hand side of
the tunnel is made up of a surface loop (residues 455–461)
that precedes helix αN near the oligomerisation domain
(Figures 1 and 2), this loop rests against helix αH. The
base of the tunnel comprises two β strands containing
Thr244 and Glu268, respectively.
There are multiple amino acid substitutions between the
ALDH1 and ALDH2 enzyme families that map to these
portions of the structure, facing into the substrate access
tunnel (Figure 2). These substitutions are generally obeyed
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Table 1
Data collection statistics.
Native 1 Native 2
X-ray source PF, BL6A Rigaku RU-200
Detector used Weissenberg RAXIS-IIC
Temperature (K) 290 113
Diffraction limit (Å) 3.10 2.35
Number of reflections 20,519 83,641
Completeness (%)* 92.6 (82.1) 95.5 (93.7)
Overall redundancy* 3.0 (2.5) 2.7 (2.6)
I/σ* 7.0 (2.6) 11.3 (2.7)
Rmerge*† 0.131 (0.319) 0.096 (0.350)
Space group P21212 P1
Asymmetric unit Dimer Tetramer
a axis (Å) 94.63 80.69
b axis (Å) 152.2 87.62
c axis (Å) 81.18 90.84
α (°) 90.00 110.5
β (°) 90.00 105.6
γ (°) 90.00 103.6
*Values in parentheses are for the highest resolution shell.
†Rmerge = Σ|I–<I>|/ΣI, where <I> is the mean of individual
observations of intensities I. All unit-cell dimensions were determined
by post-refinement within SCALEPACK, except for the Photon Factory
(PF) data where the values were averaged from individual films.
Table 2
Model statistics.
Model
No. of protein atoms 15,144
No. of water molecules 140
No. of cofactor atoms 176
Average B factors
Mainchain atoms (Å2) 28.1
Sidechain atoms (Å2) 29.7
Cofactor atoms (Å2) 34.3
Overall (Å2) 29.4
Stereochemistry
Root mean square deviations
bond lengths (Å) 0.009
bond angles (°) 1.61
planar groups (Å) 0.018
bonded mainchain B factors (Å2) 1.06
bonded sidechain B factors (Å2) 1.82
angle mainchain B factors (Å2) 1.66
angle sidechain B factors (Å2) 2.58
Noncrystallographic symmetry
Rms deviations
mainchain atoms (Å) 0.009
sidechain atoms (Å) 0.090
NAD+ atoms (Å) 0.030
Refinement
R factor* 0.236
R free† 0.258
*The R factor was calculated using 74,932 reflections within the
resolution range 100–2.35 Å. †The R free was calculated using 8274
reflections.
in all ALDH1 (retinal metabolising) and ALDH2 (acetalde-
hyde metabolising) amino acid sequences. For helix αC,
these substitutions, going from bovine ALDH2 to sheep
ALDH1 respectively, are Pro113→Leu, Ile116→Asn,
Val120→Met, Asp123→Gly, Met124→Gly, Cys128→Thr
and Tyr132→Cys. Similarly, for helix αH, the observed
substitutions are Trp285→Asn, Gln289→Phe, Phe292→
Gln, Phe296→Tyr and Asn297→His. The substitutions in
the surface loop preceding the oligomerisation interface are
Asp457→Ser, Phe459→Val, Gly460→Ser and Leu482→
Phe. In nine of these substitutions, the ALDH2 sidechains
are bulkier than their ALDH1 counterparts, and they
almost exclusively adopt conformations that result in a more
constricted entrance tunnel than in ALDH1. Several amino
acid sidechains that are identical in the ALDH1 and
ALDH2 sequences again adopt conformations in ALDH2
that make the entrance tunnel smaller than in ALDH1
(Figure 2). Examples of such residues include Lys112,
Met174, Trp177, Cys301 and Leu477; all of these residues
have well-defined electron density and lower than average
B factors in the four ALDH1 subunits. These two factors
combine with the result that the ALDH1 entrance tunnel is
much larger than that of bovine ALDH2, thereby allowing
access to larger, more bulky substrates, such as all-trans
retinal (Figure 2). In addition to amino acid substitutions,
small but concerted rigid-body movements of secondary
structure elements contribute to the opening up of the sub-
strate tunnel in ALDH1 relative to ALDH2. Indeed, the
solvent-accessible volume of the tunnel is 150 Å3 in sheep
ALDH1, but only 20 Å3 in bovine ALDH2 (when using a
1.4 Å radius probe). These observations are in accord with
all-trans retinal being a very good substrate for ALDH1, but
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Figure 1
The overall fold of the ALDH1 monomer.
(a) Stereoview superposition of a monomer of
sheep ALDH1 (yellow) and bovine ALDH2
(blue). The pairwise root mean square
difference is 0.74 Å using all mainchain
atoms. (b) Schematic diagram of the sheep
ALDH1 monomer looking into the substrate
entrance tunnel. The NAD+ (major
conformation) is also shown as a purple stick
model. Helices are shown as red cylinders
and strands are shown as blue arrows.
Secondary structure elements mentioned in
the text are labelled. (The figure was created
using the program TURBO-FRODO [61].)
a very poor substrate for ALDH2 [16]. Modelling of either
9-cis or all-trans retinal into the ALDH1 active-site tunnel
illustrates that the ALDH1 tunnel can easily accommodate
either retinoid (Figure 2), but the tunnel in ALDH2 is
too small to accommodate these bulky substrates and
steric clashes result. In the substrate modelling experiment,
the solvent-accessible surface area of the ALDH1 tunnel
decreases by 333 Å2 and that of all-trans retinal decreases by
520 Å2. These values are comparable to the published
buried surface areas of 279 Å2 (for protein) and 558 Å2 (for
all-trans retinol) in the complex formed between cellular
retinol-binding protein (CRBP) and retinol [37]. In both of
our modelled complexes, the β-ionone ring of the retinal
sticks out from the tunnel entrance and is partially exposed
to solvent. This is in contrast to what is observed in com-
plexes of CRBP and retinoic acid binding protein (CRABP)
with their respective ligands. In these complexes, the
β-ionone ring is buried to a greater extent and the solvent-
accessible cavity for the ligand is much larger — 174 Å3 and
280 Å3 for CRBP and CRABP, respectively [37,40].
Discrete disorder of the NAD+ cofactor
The adenine ring of the NAD+ cofactor sits in a hydro-
phobic pocket between helices αF and αG (Figures 1b
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Figure 2
The substrate entrance tunnel of ALDH1. 
(a) Stereoview superposition of the active-site
tunnel in ALDH1 (standard atom colours) and
ALDH2 (green) showing the major differences
in sidechain conformations between the two
isozymes. Residues that are different in
ALDH1 are labelled. The solvent-accessible
volumes for ALDH1 and ALDH2 are shown in
blue and red, respectively. (b) Stereoview
showing the results of docking all-trans retinal
(green) and 9-cis retinal (purple) in the
ALDH1 active-site tunnel. The protein atoms
are shown in standard colours; both protein
and substrate are represented as stick
models. (The figure was created using the
program TURBO-FRODO [61].)
and 3a) and its conformation is virtually identical to that
of the adenine half of the NAD+ observed in the ALDH3
[23] and ALDH2 [34] structures. As in ALDH2, the side-
chains of amino acids Gly225, Pro226, Ala230, Val249,
Leu252 and Ile253 cradle the adenine ring while the
sidechain of Ile165 makes up the base of the cradle.
Hydrogen-bonding interactions with the adenine ribose
are made by the sidechains of Lys192, Glu195 and the
mainchain carbonyl oxygen of Ile166 in both the ALDH1
and ALDH2 structures (Figure 3a).
In contrast, the nicotinamide half of the NAD+ cofactor is
strikingly different from that observed in ALDH3 and
ALDH2, and there is evidence of discrete disorder in the
nicotinamide half of NAD+ (Figure 3). After modelling and
refinement of the major NAD+ conformer (Figure 3), a
tetrahedral-shaped difference electron-density peak was
observed in |F|obs–|F|calc maps. This peak was large enough
at the 5σ level to accommodate a phosphate anion, but
made bad steric clashes with the position of the modelled
nicotinamide ring. The large difference peak was persis-
tent, and once the ALDH2 NAD+ coordinates were super-
imposed onto the sheep ALDH1 model, the ALDH2
nicotinamide phosphate was found to be coincident with
our large difference electron-density peak. Hence, we con-
cluded that the large difference peak must be due to a
second, more weakly occupied conformation of the nicotin-
amide phosphate. Indeed, when the major NAD+ con-
former is omitted from the model, there is weaker dis-
continuous |F|obs–|F|calc difference electron density at the
3σ level corresponding to the ribose and some of the
nicotinamide of the ‘second’ conformation that almost
exactly overlaps with the atomic coordinates for the nicotin-
amide half of the ALDH2 NAD+ (Figure 3b). We conclude
that the sheep ALDH1 structure contains two major confor-
mations of the nicotinamide half of the NAD+. The less
occupied conformation corresponds to the NAD+ conforma-
tion observed in the bovine ALDH2 structure [34].
Differences between the two NAD+ orientations are first
seen at the phosphate attached to the adenine ribose
(Figure 3b). In ALDH1, the adenine phosphate O1 atom
makes two hydrogen bonds: one with Ser246 Oγ and the
other with Ser246 N. The slight reorientation of the
adenine phosphate seen in our structure pivots the major
conformer of the nicotinamide phosphate to be displaced
relative to that observed in bovine ALDH2. In ALDH1
we see a hydrogen bond between Trp168 Nε1 and the
O5 atom of the nicotinamide phosphate, whereas in
ALDH2 it is O4 of the phosphate that is hydrogen
bonded to Trp168 Nε1.
The reorientation of the major NAD+ conformer observed
in our structure results in a movement of over 5 Å for the
nicotinamide ribose relative to bovine ALDH2. Indeed,
the nicotinamide ring of ALDH1 occupies nearly the same
position as the nicotinamide ribose of ALDH2 (Figure 3b).
Interactions between the nicotinamide ribose and the
protein involve Gln349, Glu399 and Phe401, as in
ALDH2, but the hydrogen bonds and van der Waals con-
tacts that they form are strikingly different (see Figure 3a).
Hence, the same amino acid residues participate in
nicotinamide binding in both ALDH1 and ALDH2, but
they do so in a distinctly different manner. In addition, the
sidechain of Lys352 makes hydrogen-bond interactions
with the nicotinamide ribose oxygen atoms in the ALDH1
structure, but this is not observed in ALDH2. The end
result is that in the ALDH1 crystal structure, the C4 atom
of the nicotinamide is too far from Cys302 Sγ (7.1 Å in
ALDH1 versus 3.7 Å in ALDH2) for direct hydride trans-
fer from a thiohemiacetal intermediate to occur during the
dehydrogenase reaction. Hence, we are likely to be
looking at a catalytically nonproductive mode of cofactor
binding in the major NAD+ conformer.
The environment of Cys302 and other active-site residues
Although the ALDH1 and ALDH2 structures super-
impose well, the orientations of several sidechains at the
active site differ in the two ALDH isozymes (Figure 2).
Of particular note is Cys301, which directly precedes the
active-site nucleophile Cys302. In sheep liver ALDH1, χ1
for Cys301 is –60°, whereas in bovine ALDH2 it is 180°,
putting the Sγ atom much closer to the Sγ atom of Cys302.
Other sidechains that exhibit different conformations are
Lys112, Met174 and Trp177, all of which line the active-
site pocket (Figure 2). On the opposite side of the active
site from Cys302 is an ion pair formed between Lys178
and Glu476; these two amino acids are conserved in the
sequences of all tetrameric ALDHs. The sidechains of both
of these residues are in slightly different orientations in
sheep ALDH1 relative to bovine ALDH2.
Not only are there differences in the sidechain conforma-
tions of several conserved amino acids at the active site,
but there are also a number of amino acid substitutions in
ALDH1 compared to ALDH2. Included in these are
Phe289, Gln292, Tyr296, His297, Ile303, Ser428, Ser457,
Val459 and Ser460, but most of these have been men-
tioned with respect to differences in the substrate entrance
tunnels of the two enzymes (Figure 2).
Possible flexibility of the general base Glu268
Mutagenesis experiments with human liver ALDH2 have
shown that Glu268 acts as a general base in both thiohemi-
acetal formation and thioester hydrolysis [33]. Although the
Glu268 sidechain in our ALDH1 structure is modelled as
the same rotamer as observed in bovine ALDH2, it exhibits
unexpectedly weak electron density (Figure 4) and high
B factors for a residue buried from solvent (average B factor
41 Å2 compared to neighbouring amino acids with average
B factors of ~25 Å2). There is no 2Fo–Fc or difference elec-
tron density for the Cα–Cβ bond if the Glu268 sidechain is
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Figure 3
NAD+ binding in ALDH1. (a) Stereoview
illustrating the major NAD+-binding mode in
ALDH1. Key residues of the protein are
labelled and hydrogen bonds are shown as
dashed lines. Carbon atoms of the protein
are shown in yellow and those of NAD+ are in
green; other atoms are in standard colours.
(b) Stereoview omit map of the NAD+-binding
region in ALDH1. The refined coordinates of
the ALDH1 NAD+ molecule (in standard atom
colours) are shown superimposed with the
ALDH2 NAD+ molecule (in green). The map
is contoured at 3σ and has not been
cushioned or cosmetically altered. Surface
representations of (c) the ALDH1 and (d) the
ALDH2 monomers in the vicinity of the NAD+-
binding site, coloured by electrostatic
potential. Bound NAD+ is shown in stick
representation. Note the large region of
negative electrostatic potential near the
NAD+ pyrophosphate. (Figures (a) and (b)
were generated using the program TURBO-
FRODO [61]; figures (c) and (d) were
generated using the program GRASP [62].)
removed during least squares refinement. Glu268 is likely
to be hydrogen bonded to the nicotinamide ring amide
nitrogen of our low occupancy nicotinamide conformer, as
observed in ALDH2, or to a higher occupancy water mol-
ecule ~4 Å from the Glu268 carboxylate in ALDH1 (shown
as a green difference electron-density peak in Figure 4).
However, the height of this water peak varies in each of
our four independent active sites, suggesting variable
occupancy. We have therefore not included this potential
water molecule in our refined model. If this was the dea-
cylating water molecule for ALDH1, it is difficult to
imagine how it would be held in place as it makes no good
hydrogen bonds with the protein. However, it is posi-
tioned approximately the correct distance from Cys302 Sγ
to hydrolyse the envisaged thioester intermediate.
Discussion
The substrate entrance tunnel
The obvious difference in the size and shape of the sub-
strate entrance tunnel of ALDH1 relative to ALDH2
reinforces what is known about the substrate specificities
of these enzymes. The ALDH1 tunnel is more open
than its counterpart in ALDH2, and hence ALDH1 must
clearly accommodate larger, bulkier substrates than
ALDH2. ALDH1 prefers retinal as a substrate, whereas
ALDH2 prefers acetaldehyde. In fact, the converse is
also true as retinal is a poor substrate of ALDH2, and
acetaldehyde is a relatively poor substrate of ALDH1.
The size of the substrate entrance tunnel may also
explain the differential reactivities of ALDH1 and
ALDH2 towards the ALDH inhibitor disulfiram. Disulfi-
ram is a bulky, hydrophobic compound that reacts
quickly with ALDH1 and more slowly with ALDH2
[42–44]. We anticipated that the ALDH1 active site
would be more hydrophobic than that of ALDH2, but in
fact there are more polar residues lining the ALDH1
substrate entrance tunnel. As in the case of retinal, we
conclude that it is more likely to be the size and shape of
the substrate entrance tunnel, rather than its hydro-
phobicity, that confers differential disulfiram reactivity
in the two ALDH isozymes. This fits with earlier sugges-
tions that it is their inherent bulkiness and size that pre-
disposes all-trans retinal, disulfiram and other compounds
to preferential interaction with ALDH1 [45]. A recent
study [46] reported that alcoholic patients being treated
with disulfiram develop symptoms attributable to a build-
up of retinoic acid precursors, suggesting the involve-
ment of ALDH1 in complications associated with disul-
firam therapy. With knowledge of both the ALDH1 and
ALDH2 structures, it should now be possible to synthe-
sise effective ALDH2 inhibitors that do not interfere
with the function of ALDH1.
The change in the conformation of the N-terminal segment
and several nearby loops surrounding the entrance to the
substrate tunnel suggests that surface differences are
important to ALDH structure and function, at least in
terms of access to substrate. There is kinetic evidence
that retinal-loaded intracellular retinal binding protein
(CRBP II) [38] is a good substrate for ALDH1 [5,14]. If,
in vivo, the retinal substrate is passed directly from
CRBP II to ALDH1, it is an attractive idea that the mol-
ecular surface of ALDH1 in the vicinity of the substrate
tunnel entrance could be important for recognition and
binding of CRBP II by ALDH1. Indeed, ALDH1 could
also conceivably pass its product, retinoic acid, directly to
one of the intracellular retinoic acid binding proteins.
However, experimental work is required to show whether
there are specific interactions between ALDH1 and
retinoid-binding proteins.
Reorientation of NADH as a critical component of the
ALDH mechanism
In the ALDH enzymes, NAD+ binding appears to be both
flexible and highly variable for the nicotinamide half of
the cofactor. ALDH1, ALDH2 and ALDH3 all exhibit
different binding modes for the nicotinamide half of the
cofactor, although the adenine moiety interacts with the
protein almost identically in all three enzyme structures
determined to date. This observation suggests that move-
ment of the nicotinamide ring in and out of the active site
is a conserved and important component of the functional
enzyme. Our observation that the general base Glu268
also exhibits disorder in ALDH1, and taking into consid-
eration chemical requirements for both the dehydrogenase
and deacylation steps of the reaction, leads us to suggest
that movement of the NAD+ cofactor and Glu268 are
coupled in the ALDH reaction mechanism. Specifically,
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Figure 4
A view of ALDH1 showing the 2Fo–Fc electron density in blue
contoured at 0.9σ in the vicinity of Glu268. Fo–Fc density for a
possible deacylating water molecule is shown in green at 3.0σ. (The
figure was created using the program TURBO-FRODO [61].)
during hydride transfer from the Cys302 thiohemiacetal to
the NAD+ nicotinamide, the sidechain of Glu268 must be
‘tucked away’ from the nicotinamide ring of the cofactor,
as it is primarily observed to be in all ALDH crystal struc-
tures. Before deacylation of the thioester can take place,
the reduced nicotinamide ring must at least partially exit
the active-site pocket to make room for a water molecule
to position itself near the thioester carbon atom of the acyl
intermediate. Glu268 most likely abstracts a proton from
this deacylating water, and would have to move from its
modelled position to do this. Hence, we believe that the
sidechain of Glu268 has two conformations: a passive con-
former that ‘stays out of the way’ to allow hydride transfer
to the nicotinamide, and an active conformer that partici-
pates in proton abstraction from a thioester-deacylating
water molecule. The active site general base Glu268
[28,33] is buried away from the solvent in the active site,
and is too far from Cys302 to act directly as a base [34],
hence the necessity for a deacylating water molecule.
An idea that directly follows the requirement for flexibil-
ity in NAD+ binding is that the novel mode of NAD+
binding in the N-terminal domain of ALDHs somehow
facilitates the flexibility required in the nicotinamide half
of the cofactor. In contrast to other NAD+-dependent
dehydrogenases, there are few interactions between the
NAD+ phosphates and the protein; especially lacking are
lysine or arginine residues at the phosphate-binding site or
a strong interaction between the phosphates and the
N terminus of a helix dipole. In contrast, there is a patch
of strong negative electrostatic potential near the NAD+
phosphate binding pocket that is conserved, at least
between ALDH1 and ALDH2 (Figure 3c). This suggests
to us that binding of the pyrophosphate of NAD+ in
ALDH is intentionally weak, so that the phosphates can
act as a flexible ‘ball-and-socket’ swivel, allowing the
nicotinamide moiety to adopt different conformations
during the individual steps of the reaction pathway.
Biological implications
Retinoic acid is required for the correct formation of
many organs and structures during vertebrate develop-
ment, including the spinal chord, retina and heart. Main-
tenance of adult epithelial cell type is also mediated by
retinoic acid. All of the known effects of retinoic acid are
due to the binding of all-trans or 9-cis retinoic acid to
nuclear retinoic acid receptors, which act as transcrip-
tion factors and regulate gene expression in the cell
nucleus. The cytosolic isoform of aldehyde dehydroge-
nase (ALDH1) is the single most important enzyme for
the production of all-trans and 9-cis retinoic acid in ver-
tebrate cells, and retinal dehydrogenase activity has been
shown to localise with high concentrations of retinoic
acid during embryonic spinal chord formation. Factors
that attenuate retinal dehydrogenase activity in living
cells are not well characterised, and it is hoped that
structural information pertaining to the retinal-specific
ALDH1 isozyme will aid in understanding how the
spatiotemporal distributions of retinoic acid are con-
trolled during vertebrate development.
The three-dimensional structure of sheep liver ALDH1
has been determined and compared to that of the mito-
chondrial ALDH2 isozyme. Comparisons of the two
enzymes reveal that the major differences are localised
to the substrate-binding tunnel and to the mode of
NAD+ cofactor binding. The size and shape of the
ALDH1 substrate entrance tunnel is likely to be the
primary determinant of retinal specificity for this enzyme.
In contrast, the ALDH2 substrate tunnel is too con-
stricted to accept retinal, and prefers acetaldehyde as a
substrate. We contend that the large size of the ALDH1
substrate entrance tunnel relative to ALDH2 is respon-
sible for the increased reactivity in vitro of ALDH1 to
the alcohol aversive drug disulfiram.
The presence of two discretely ordered conformers of
NAD+ in the ALDH1 structure argues strongly for an
enzyme reaction mechanism in which the nicotinamide
portion of the cofactor can move in and out of the active-
site pocket, tethered to a flexible arm (the nicotinamide
phosphate and ribose), while the adenine half of the
cofactor acts as a rigid anchor. This observation is in
agreement with the two-step nature of the chemistry
involved in aldehyde dehydrogenation and enzyme–thio-
ester hydrolysis during the reaction cycle. In this pro-
posed reaction scenario, the general base Glu268 must
also be mobile to accommodate productive NAD(H)
binding and to function in both thiohemiacetal formation
and thioester hydrolysis. The observed disorder of the
Glu268 sidechain in all four subunits of the sheep
ALDH1 structure supports this hypothesis.
Materials and methods
Isolation, purification and crystallisation of sheep liver ALDH1
Sheep liver cytosolic ALDH was isolated and purified as described previ-
ously [47]. Fractions containing active ALDH were identified by enzyme
assay using acetaldehyde as substrate and monitoring the appearance of
NADH spectrophotometrically at 340 nm. The final fractions were
assayed for activity and checked for purity by sodium dodecyl sulphate
(SDS) polyacrylamide gel electrophoresis and isoelectric focusing. The
purest fractions were then pooled, dialysed against 50 mM Na/K phos-
phate, pH 7.4, 1 mM DTT and concentrated to 10 mg/ml protein using
microconcentrators. Crystals were grown using the hanging-drop vapour
diffusion technique as described previously [48]. The protein concentra-
tion was 10 mg/ml with 1 mM NAD+, and the reservoir solution contained
170 mM MgCl2, 100 mM Bis-Tris-propane (pH 6–7) and 6–7% w/v
monomethylether polyethylene glycol (PEG) 5000. Drops were typically
4 µl to 6 µl and contained equal volumes of the protein solution and pre-
cipitant. The crystals tended to grow over a very narrow PEG concentra-
tion and often several trays would only yield one or two usable crystals.
We routinely observed three crystal forms: a thin plate habit that
belonged to a C-centred orthorhombic lattice (a = 170.8, b = 330.7,
c = 80.77 Å) containing one tetramer per asymmetric unit; a cuvette habit
that was in space group P21212 (a = 92.9, b = 151.3, c = 81.4 Å) with
one dimer per asymmetric unit; and a chunky plate habit that was triclinic
(a = 80.69, b = 87.62, c = 90.84 Å, α = 110.5, β = 105.6, γ = 103.6°)
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and contained a tetramer in the P1 unit cell. Most of the crystals dif-
fracted poorly, either at room temperature or flash frozen at liquid nitro-
gen temperatures, but about 10% diffracted well. The triclinic crystals
were of the best quality, and after flash freezing in mother liquor plus
30% v/v glycerol, diffracted to nearly 2.0 Å resolution. The average
mosaic spread for a typical crystal was about 1.0° after freezing. Data for
the P21212 cell were collected on beamline BL-6A (λ = 1.000 Å) at the
Photon Factory, Tsukuba Japan, using imaging plates on a Weissenberg
Camera at a temperature of 12°C. Crystals of the triclinic cell were flash
frozen at 113K, and diffraction data were recorded using a Rigaku Rax-
isIIC imaging plate detector, with 0.1 mm collimated Cu-Kα radiation
(λ = 1.5418 Å) from a Rigaku RU-200B rotating-anode generator operat-
ing at 50 kV, 100 mA. All data were indexed, and integrated with the
program DENZO [49] and initially post-refined with SCALEPACK [49] to
determine an accurate unit cell. The images were reprocessed with the
post-refined cell parameters and individual films were scaled and merged
with SCALEPACK. Profile-fitted intensities were converted to amplitudes
using the CCP4 program TRUNCATE [50,51].
Structure solution and refinement
The orthorhombic crystal form was first solved by using the refined coor-
dinates of a monomer of bovine ALDH2 (coordinates kindly provided by T
Hurley). With data from 10–3.2 Å, the cross-rotation function in AMoRe
[52] yielded two clear peaks. The first peak was at Eulerian angles
α = 10.71°, β = 60.76°, γ = 88.16° with height 14.8 (rms = 1.7). The
second peak was at α = 146.95°, β = 60.35°, γ = 88.17° with a height
of 13.3. A translation function in space group P21212 (10–3.2 Å data)
gave a clear solution for both the first (correlation coefficient = 0.308,
R factor = 0.504) and second (correlation coefficient = 0.262, R factor =
0.519) cross-rotation peaks. Fixing the first solution, and searching for the
second translation vector resulted in a correlation coefficient of 0.513
and an R factor of 0.431. Rigid-body refinement improved the solu-
tions, yielding a final correlation coefficient of 0.643 (R factor = 0.383).
After dissimilar sidechains between sheep ALDH1 and bovine ALDH2
were truncated to alanine, SIGMAA-weighted maps [53] were calculated
and many missing sidechains were easily built into the electron-density
maps. The maps were of excellent quality, despite the poor merging
statistics of the diffraction data (Rmerge = 0.13). Four rounds of TNT
refinement [54,55] using NCS constraints on the two monomers in the
crystallographic asymmetric unit, followed by model building into
SIGMAA-weighted 2Fo–Fc and Fo–Fc maps yielded a free R factor of
31% (for 10% of the data) between 30.0 and 3.1 Å resolution. The
working R factor was 26% and one B factor was modelled per residue.
At this resolution, it was difficult to fit the NAD+ electron density unam-
biguously, but the fitting of the adenine half of the cofactor was relatively
straightforward. Once the triclinic data became available, we carried out
molecular replacement using the partially refined orthorhombic model.
The rotation function solution for the orthorhombic tetramer was straight-
forward in AMoRe with a peak height of 63 (rms = 2.0); the next highest
peak was 10.0. The nature of the rotation solution suggested the triclinic
and orthorhombic cells were very closely related. Least squares refine-
ment in TNT using a maximum likelihood target [56] followed by model
building and eventual refinement in CNS [57], resulted in a free R factor
of 25.8% for a randomly chosen 10% of the data (see Table 1). In all
refinements, the bond length and angle parameters of Engh and Huber
were used [58]. The quality of the electron-density maps was excellent
and a model for the complete polypeptide, excluding residues –1 to 6,
was built. Amino acid sidechains for Lys56, Arg86, Lys357, Lys411 and
Lys418 were not included in the final model due to apparent disorder,
and these amino acids were modelled as alanine. A total of 140 water
molecules were added to the tetrameric structure. This corresponded to
35 unique and identical water molecules per ALDH1 monomer. Although
high concentrations of Mg2+ ions were present in the crystallisation solu-
tions and appeared necessary for growth of ALDH1 crystals, we did not
conclusively identify any Mg2+ ions in the sheep ALDH1 structure. During
positional refinement of the model, strict NCS restraints were maintained
giving a final rmsd between monomers of 0.009 Å. Although two confor-
mations of the nicotinamide half of the NAD+ cofactor were apparent in
difference and omit electron-density maps, only the highest occupancy
NAD+ conformer (about 80% occupancy) was used for the structure-
factor calculations and least-squares refinement. Analysis of the final
coordinates with PROCHECK [59] revealed excellent stereochemistry,
with 89% of residues in the most favoured regions and 10.2% in addi-
tional allowed regions. The rmsd values for bonds and angles, as well as
other refinement statistics, are given in Table 2.
Modelling of all-trans and 9-cis retinal in the ALDH1 active site
All-trans retinal and its 9-cis isomer were docked into the ALDH1 active
site manually, using the retinoic acid coordinates from human CRABP II
(PDB code 1CBS) [40]. Solvent-accessible volumes of the tunnels
before docking were calculated with the program VOIDOO [60] and
solvent-accessible surface areas before and after docking of retinal were
calculated using programs in the CCP4 suite [50]. Close contacts were
examined and adjusted using TURBO-FRODO [61]. The sidechain of
Met120 was manually adjusted to relieve bad contacts for both retinoid
complexes. No carbon–carbon contact distances less than 3.4 Å were
observed in the modelled retinal complexes. The retinal coordinates were
adjusted such that the aldehyde carbonyl carbon made close contact
with the Sγ of Cys302 (2.5 Å) in anticipation of thiohemicacetal formation,
the aldehyde hydrogen was in a reasonable position for hydride transfer,
and the aldehyde carbonyl oxygen was pointing at the presumed oxyanion
hole making hydrogen bonds with Cys302 NH and Asn169 Nδ2.
Accession numbers
The atomic coordinates for the triclinic form of sheep liver ALDH1 have
been deposited in the Brookhaven Protein Data Bank with accession
code 1bxs.
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